Among patients with diabetic polyneuropathy (a disorder of the peripheral nerves that can give rise to pain, pins-and-needles sensations, burning or numbness in the arms and legs), a course of BEMER therapy lasting several weeks was successful in significantly improving the function of the subcutaneous microcirculation and the immune system.
Another study demonstrated that, where diabetes patients receiving conservative, outpatient treatment had undergone a 27-day course of BEMER therapy on their sores, these became significantly smaller than on diabetes patients in the control group. It was therefore possible to significantly improve the impaired healing of sores.
Viewed in a holistic therapeutic concept, this makes BEMER Physical Vascular Therapy an absolutely essential complementary treatment in the therapy of metabolic disorders such as diabetes mellitus and the prevention of metabolic syndrome, especially in these modern times dominated by stress and lack of exercise.
Diabetes mellitus has since become such a widespread disease that some have termed it the "epidemic of the century". Looking at some figures, it quickly becomes apparent that this name is not entirely undeserved. According to the OECD, diabetes prevalence (i.e. the frequency of diabetes occurrence) in 2010 averaged 6.5 percent (5.3 percent in the Netherlands, 6.7 percent in France, 8.9 percent in Germany and as much as 10.3 percent in the USA). According to information from the IDF (International Diabetes Foundation), it is to be expected that this number in Germany will rise to at least 13 percent by 2030. Considering the prevalence of the disease in respect of age, we see that it grows with increased age. It was shown for example by the results of the DEGS study that among 40 to 49-year-olds, 2 percent of men and 4.5 percent of women suffer from diabetes. In the 70 to 79 age group, the proportion is already around 22 percent. As a result of this high number of sufferers, the cost burden on the healthcare system is naturally enormous. The results of the CoDiM study, for example, have shown that the direct costs of diabetes in Germany are already in excess of 30 billion euros each year.
Diabetes mellitus (meaning "honey-sweet flow") or type 2 diabetes is colloquially referred to simply as diabetes. This metabolic disorder is part of what is known as the "metabolic syndrome", the main culprit in the development of arteriosclerosis (hardening of the arteries) and coronary heart disease (a disorder of the coronary vessels). In addition to diabetes, the following factors are part of this syndrome: Abdominal obesity, high blood pressure (hypertension) and abnormal blood fat levels (dyslipidemia). The prevalence of this syndrome among adults in Germany is around 20 percent among women and 25 percent among men. Although a wide variety of factors play a role in its development, the combination of excessive calorie consumption, poor diet and lack of exercise are among the main causes. This is why the risk factors for diabetes are considered to be too many meals, obesity, android fat distribution (fat distribution mostly around the trunk, also referred to as an "apple shape" and mainly observed in men), age and, indeed, lack of exercise.
What does Diabetes cause in the body?
Increased intake of calories frequently results in elevated blood sugar levels, which causes the pancreas to try and generate more insulin. The pancreas is an organ that weighs 70–100g and merges with the bile duct below the gastric outlet to enter the C-shaped duodenum. To perform its key function of digesting carbohydrates, fats and proteins, it contains two fundamentally different cell structures. Firstly, the exocrine glands (exocrine meaning "dispensing outwards" – in this case to the digestive tract), which produce an alkaline digestive secretion that contains among other things key enzymes for the digestion of fats and proteins. Secondly, the endocrine glands (endocrine meaning "dispensing inwards" – in this case to the blood), consisting of beta cells arranged like an island (hence the name "insulin") which normally produce around 2 milligrams of insulin a day. This hormone is normally responsible for transporting sugar, amino acids and fats to the body's cells and is therefore also often referred to as a "storage hormone". After years or decades, however, the pancreas becomes exhausted from this high level of production, and the blood sugar level rises. Although this as yet insulin-independent diabetes could still be treated with a proper diet and exercise, the result for many patients is that they have to inject insulin.
Around 90 percent of diabetes patients have type 2 diabetes. These patients have usually had the disease for several years before it is even diagnosed, as it is often – especially at the beginning – associated with non-specific symptoms such as tiredness, weakness, impaired vision and propensity for infection (including frequent bladder infections). Weight loss is rare, and increased thirst and the need to urinate are only observed where blood sugar levels are extremely high. This is why such a diagnosis is frequently made by chance.
Diabetes mellitus, Type 1
One of the other types is type 1 diabetes mellitus. Here, the pancreas either generates too little insulin or none at all. The causes of this type of disorder are not yet fully known. Causes are believed to be genetic factors, autoimmune reactions, environmental burdens or viral infections. A defining aspect of type 1 diabetes is pronounced weight loss over a few weeks. Further symptoms are dehydration, a constant thirst, frequent urination, vomiting, and occasionally calf cramps and abdominal pains. More general symptoms such as tiredness, lack of energy, impaired vision, lack of concentration and headaches are also possible.
Prognosis for Diabetes Patients
The prognosis for diabetes patients is therefore clearly dependent on these consequential disorders. Patients who make appropriate lifestyle changes in accordance with relevant recommendations (diet plus exercise as a base therapy) can reduce the likelihood of suffering from such consequential disorders considerably, thereby improving their prognosis substantially. The ultimate goal of diabetics is to achieve a reduction in blood sugar and HbA1c values. Put simply, the HbA1c value provides information about the sugar levels of the cells and cell membranes. High blood sugar levels will result in high HbA1c values and therefore give rise to a high probability of suffering from consequential disorders. If the base therapy does not have the desired success, namely achieving the prescribed target HbA1c value, pharmaceutical therapy is provided by means of orally administered anti-diabetic drugs. If this therapy is not successful, the final resort is treatment using insulin.